Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 440

1.

T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers.

Asaka S, Yen TT, Wang TL, Shih IM, Gaillard S.

Mod Pathol. 2018 Nov 6. doi: 10.1038/s41379-018-0172-x. [Epub ahead of print]

PMID:
30401949
2.

Gallium nitride nanowire as a linker of molybdenum sulfides and silicon for photoelectrocatalytic water splitting.

Zhou B, Kong X, Vanka S, Chu S, Ghamari P, Wang Y, Pant N, Shih I, Guo H, Mi Z.

Nat Commun. 2018 Sep 21;9(1):3856. doi: 10.1038/s41467-018-06140-1.

3.

Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.

Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM.

Cancer Prev Res (Phila). 2018 Nov;11(11):697-706. doi: 10.1158/1940-6207.CAPR-18-0009. Epub 2018 Sep 19.

PMID:
30232083
4.

Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic.

Stone ML, Chiappinelli KB, Li H, Murphy LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, Hung CF, Bhargava V, Wiehagen KR, Cowley GS, Bachman KE, Strick R, Strissel PL, Baylin SB, Zahnow CA.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8583-E8584. doi: 10.1073/pnas.1811015115. Epub 2018 Sep 4. No abstract available.

PMID:
30181297
5.

Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.

Yen TT, Miyamoto T, Asaka S, Chui MH, Wang Y, Lin SF, Stone RL, Fader AN, Asaka R, Kashima H, Shiozawa T, Wang TL, Shih IM, Tanner EJ 3rd.

Gynecol Oncol. 2018 Sep;150(3):426-431. doi: 10.1016/j.ygyno.2018.06.025. Epub 2018 Jul 4.

PMID:
30126589
6.

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.

Pisanic TR 2nd, Cope LM, Lin SF, Yen TT, Athamanolap P, Asaka R, Nakayama K, Fader AN, Wang TH, Shih IM, Wang TL.

Clin Cancer Res. 2018 Aug 14. doi: 10.1158/1078-0432.CCR-18-1199. [Epub ahead of print]

PMID:
30108103
7.

Photoelectrochemical CO2 Reduction into Syngas with the Metal/Oxide Interface.

Chu S, Ou P, Ghamari P, Vanka S, Zhou B, Shih I, Song J, Mi Z.

J Am Chem Soc. 2018 Jun 27;140(25):7869-7877. doi: 10.1021/jacs.8b03067. Epub 2018 Jun 15.

PMID:
29905471
8.

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway.

Yu Y, Suryo Rahmanto Y, Lee MH, Wu PH, Phillip JM, Huang CH, Vitolo MI, Gaillard S, Martin SS, Wirtz D, Shih IM, Wang TL.

Oncogene. 2018 Jul;37(28):3778-3789. doi: 10.1038/s41388-018-0241-0. Epub 2018 Apr 11.

9.

Independent development of endometrial epithelium and stroma within the same endometriosis.

Noë M, Ayhan A, Wang TL, Shih IM.

J Pathol. 2018 Jul;245(3):265-269. doi: 10.1002/path.5082. Epub 2018 May 2.

PMID:
29604057
10.

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.

Fukumoto T, Park PH, Wu S, Fatkhutdinov N, Karakashev S, Nacarelli T, Kossenkov AV, Speicher DW, Jean S, Zhang L, Wang TL, Shih IM, Conejo-Garcia JR, Bitler BG, Zhang R.

Cell Rep. 2018 Mar 27;22(13):3393-3400. doi: 10.1016/j.celrep.2018.03.019.

11.

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I, Sundfelt K, Kjær SK, Hruban RH, Shih IM, Wang TL, Kurman RJ, Springer S, Ptak J, Popoli M, Schaefer J, Silliman N, Dobbyn L, Tanner EJ, Angarita A, Lycke M, Jochumsen K, Afsari B, Danilova L, Levine DA, Jardon K, Zeng X, Arseneau J, Fu L, Diaz LA Jr, Karchin R, Tomasetti C, Kinzler KW, Vogelstein B, Fader AN, Gilbert L, Papadopoulos N.

Sci Transl Med. 2018 Mar 21;10(433). pii: eaap8793. doi: 10.1126/scitranslmed.aap8793.

PMID:
29563323
12.

WITHDRAWN: International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.

Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X.

Int J Gynecol Pathol. 2018 Apr 11. doi: 10.1097/PGP.0000000000000496. [Epub ahead of print]

PMID:
29521846
13.

Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer.

Chen BB, Tien YW, Chang MC, Cheng MF, Chang YT, Yang SH, Wu CH, Kuo TC, Shih IL, Yen RF, Shih TT.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1205-1217. doi: 10.1007/s00259-018-3960-0. Epub 2018 Feb 23.

PMID:
29476229
14.

CINdex: A Bioconductor Package for Analysis of Chromosome Instability in DNA Copy Number Data.

Song L, Bhuvaneshwar K, Wang Y, Feng Y, Shih IM, Madhavan S, Gusev Y.

Cancer Inform. 2017 Dec 13;16:1176935117746637. doi: 10.1177/1176935117746637. eCollection 2017.

15.

Indonesian scientists embrace preprint server.

Shih I.

Nature. 2018 Jan 11;553(7687):139. doi: 10.1038/d41586-017-08838-6. No abstract available.

PMID:
29323327
16.

Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.

Ojalvo LS, Thompson ED, Wang TL, Meeker AK, Shih IM, Fader AN, Cimino-Mathews A, Emens LA.

Hum Pathol. 2018 Apr;74:135-147. doi: 10.1016/j.humpath.2017.12.010. Epub 2017 Dec 27.

PMID:
29288043
17.

Precancerous Lesions of Ovarian Cancer-A US Perspective.

Visvanathan K, Wang TL, Shih IM.

J Natl Cancer Inst. 2018 Jul 1;110(7):692-693. doi: 10.1093/jnci/djx269. No abstract available.

PMID:
29281080
18.

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

Stone ML, Chiappinelli KB, Li H, Murphy LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, Hung CF, Bhargava V, Wiehagen KR, Cowley GS, Bachman KE, Strick R, Strissel PL, Baylin SB, Zahnow CA.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10981-E10990. doi: 10.1073/pnas.1712514114. Epub 2017 Dec 4.

19.

The novel ZIP4 regulation and its role in ovarian cancer.

Fan Q, Cai Q, Li P, Wang W, Wang J, Gerry E, Wang TL, Shih IM, Nephew KP, Xu Y.

Oncotarget. 2017 Sep 30;8(52):90090-90107. doi: 10.18632/oncotarget.21435. eCollection 2017 Oct 27.

20.

Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.

Wu RC, Veras E, Lin J, Gerry E, Bahadirli-Talbott A, Baras A, Ayhan A, Shih IM, Wang TL.

Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6). pii: a001693. doi: 10.1101/mcs.a001693. Print 2017 Nov.

21.

Endometriosis: benign, malignant, or something in between?

Chui MH, Wang TL, Shih IM.

Oncotarget. 2017 Sep 19;8(45):78263-78264. doi: 10.18632/oncotarget.21051. eCollection 2017 Oct 3. No abstract available.

22.

High grade serous ovarian carcinomas originate in the fallopian tube.

Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, Tille JC, Bowden M, Ayhan A, Wood LD, Scharpf RB, Kurman R, Wang TL, Shih IM, Karchin R, Drapkin R, Velculescu VE.

Nat Commun. 2017 Oct 23;8(1):1093. doi: 10.1038/s41467-017-00962-1.

23.

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.

Ducie J, Dao F, Considine M, Olvera N, Shaw PA, Kurman RJ, Shih IM, Soslow RA, Cope L, Levine DA.

Nat Commun. 2017 Oct 17;8(1):990. doi: 10.1038/s41467-017-01217-9.

24.

Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma.

Xing D, Suryo Rahmanto Y, Zeppernick F, Hannibal CG, Kjaer SK, Vang R, Shih IM, Wang TL.

Hum Pathol. 2017 Oct;68:87-91. doi: 10.1016/j.humpath.2017.08.021. Epub 2017 Sep 2.

25.

Toward Single Atom Chains with Exfoliated Tellurium.

Churchill HOH, Salamo GJ, Yu SQ, Hironaka T, Hu X, Stacy J, Shih I.

Nanoscale Res Lett. 2017 Aug 10;12(1):488. doi: 10.1186/s11671-017-2255-x.

26.

Lymphocytic hidradenitis: A distinctive histopathological finding of annular erythema of Sjögren syndrome.

Hsu HC, Lin CY, Shih IH, Shen SC.

Australas J Dermatol. 2018 Aug;59(3):e198-e202. doi: 10.1111/ajd.12700. Epub 2017 Aug 3.

PMID:
28771678
27.

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

Fader AN, Bergstrom J, Jernigan A, Tanner EJ 3rd, Roche KL, Stone RL, Levinson KL, Ricci S, Wethingon S, Wang TL, Shih IM, Yang B, Zhang G, Armstrong DK, Gaillard S, Michener C, DeBernardo R, Rose PG.

Gynecol Oncol. 2017 Oct;147(1):85-91. doi: 10.1016/j.ygyno.2017.07.127. Epub 2017 Jul 30.

PMID:
28768570
28.

Physical activity modifies the influence of apolipoprotein E ε4 allele and type 2 diabetes on dementia and cognitive impairment among older Mexican Americans.

Shih IF, Paul K, Haan M, Yu Y, Ritz B.

Alzheimers Dement. 2018 Jan;14(1):1-9. doi: 10.1016/j.jalz.2017.05.005. Epub 2017 Jul 8.

PMID:
28692819
29.

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM.

Intest Res. 2017 Jul;15(3):285-310. doi: 10.5217/ir.2017.15.3.285. Epub 2017 Jun 12. Review.

30.

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM.

Intest Res. 2017 Jul;15(3):266-284. doi: 10.5217/ir.2017.15.3.266. Epub 2017 Jun 12. Review.

31.

PET/MRI for evaluating subclinical inflammation of ulcerative colitis.

Shih IL, Wei SC, Yen RF, Chang CC, Ko CL, Lin BR, Shun CT, Liu KL, Wong JM, Chang YC.

J Magn Reson Imaging. 2018 Mar;47(3):737-745. doi: 10.1002/jmri.25795. Epub 2017 Jun 22.

PMID:
28640521
32.

Cancer-Associated Mutations in Endometriosis without Cancer.

Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, Ho J, Wu RC, Lac V, Ogawa H, Tessier-Cloutier B, Alhassan R, Wang A, Wang Y, Cohen JD, Wong F, Hasanovic A, Orr N, Zhang M, Popoli M, McMahon W, Wood LD, Mattox A, Allaire C, Segars J, Williams C, Tomasetti C, Boyd N, Kinzler KW, Gilks CB, Diaz L, Wang TL, Vogelstein B, Yong PJ, Huntsman DG, Shih IM.

N Engl J Med. 2017 May 11;376(19):1835-1848. doi: 10.1056/NEJMoa1614814.

33.

Occupational and recreational physical activity and Parkinson's disease in Denmark.

Shih IF, Starhof C, Lassen CF, Hansen J, Liew Z, Ritz B.

Scand J Work Environ Health. 2017 May 1;43(3):210-216. doi: 10.5271/sjweh.3633. Epub 2017 Mar 20.

PMID:
28319247
34.

Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer.

Tang Z, Steranka JP, Ma S, Grivainis M, Rodić N, Huang CR, Shih IM, Wang TL, Boeke JD, Fenyö D, Burns KH.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E733-E740. doi: 10.1073/pnas.1619797114. Epub 2017 Jan 17.

35.

Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.

Lin SF, Gerry E, Shih IM.

J Pathol. 2017 May;242(1):3-6. doi: 10.1002/path.4875. Epub 2017 Mar 23. Review.

PMID:
28054715
36.

Cancer Implications for Patients with Endometriosis.

Wilbur MA, Shih IM, Segars JH, Fader AN.

Semin Reprod Med. 2017 Jan;35(1):110-116. doi: 10.1055/s-0036-1597120. Epub 2017 Jan 3. Review.

PMID:
28049216
37.
38.

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.

Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL.

Cancer Res. 2016 Nov 1;76(21):6351-6361. Epub 2016 Sep 2.

39.

CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.

Ayhan A, Kuhn E, Wu RC, Ogawa H, Bahadirli-Talbott A, Mao TL, Sugimura H, Shih IM, Wang TL.

Mod Pathol. 2017 Feb;30(2):297-303. doi: 10.1038/modpathol.2016.160. Epub 2016 Oct 21.

40.

Biologically inspired survival analysis based on integrating gene expression as mediator with genomic variants.

Youssef I, Clarke R, Shih IeM, Wang Y, Yu G.

Comput Biol Med. 2016 Oct 1;77:231-9. doi: 10.1016/j.compbiomed.2016.08.020. Epub 2016 Aug 31.

PMID:
27619193
41.

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors.

Ayhan A, Mao TL, Suryo Rahmanto Y, Zeppernick F, Ogawa H, Wu RC, Wang TL, Shih IeM.

J Pathol Clin Res. 2015 May 27;1(3):186-93. doi: 10.1002/cjp2.22. eCollection 2015 Jul.

42.

CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.

Kuhn E, Wang TL, Doberstein K, Bahadirli-Talbott A, Ayhan A, Sehdev AS, Drapkin R, Kurman RJ, Shih IeM.

Mod Pathol. 2016 Oct;29(10):1254-61. doi: 10.1038/modpathol.2016.101. Epub 2016 Jul 22.

43.

Correction: Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube.

Kito M, Maeda D, Kudo-Asabe Y, Sato N, Shih IM, Wang TL, Tanaka M, Terada Y, Goto A.

PLoS One. 2016 Jul 21;11(7):e0160136. doi: 10.1371/journal.pone.0160136. eCollection 2016.

44.

Diagnostic potential of tumor DNA from ovarian cyst fluid.

Wang Y, Sundfeldt K, Mateoiu C, Shih IeM, Kurman RJ, Schaefer J, Silliman N, Kinde I, Springer S, Foote M, Kristjansdottir B, James N, Kinzler KW, Papadopoulos N, Diaz LA, Vogelstein B.

Elife. 2016 Jul 15;5. pii: e15175. doi: 10.7554/eLife.15175.

45.

Treatment of Seborrhoeic Dermatitis in Asia: A Consensus Guide.

Cheong WK, Yeung CK, Torsekar RG, Suh DH, Ungpakorn R, Widaty S, Azizan NZ, Gabriel MT, Tran HK, Chong WS, Shih IH, Dall'Oglio F, Micali G.

Skin Appendage Disord. 2016 May;1(4):187-96. doi: 10.1159/000444682. Epub 2016 Mar 23.

46.

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, Cha SW, Aiyetan P, Woo S, Tian Y, Gritsenko MA, Clauss TR, Choi C, Monroe ME, Thomas S, Nie S, Wu C, Moore RJ, Yu KH, Tabb DL, Fenyö D, Bafna V, Wang Y, Rodriguez H, Boja ES, Hiltke T, Rivers RC, Sokoll L, Zhu H, Shih IM, Cope L, Pandey A, Zhang B, Snyder MP, Levine DA, Smith RD, Chan DW, Rodland KD; CPTAC Investigators.

Cell. 2016 Jul 28;166(3):755-765. doi: 10.1016/j.cell.2016.05.069. Epub 2016 Jun 29.

47.

PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.

Veras E, Kurman RJ, Wang TL, Shih IM.

Int J Gynecol Pathol. 2017 Mar;36(2):146-153. doi: 10.1097/PGP.0000000000000305.

48.

Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube.

Kito M, Maeda D, Kudo-Asabe Y, Sato N, Shih IeM, Wang TL, Tanaka M, Terada Y, Goto A.

PLoS One. 2016 Jun 3;11(6):e0156069. doi: 10.1371/journal.pone.0156069. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0160136.

49.

Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Sherman ME, Drapkin RI, Horowitz NS, Crum CP, Friedman S, Kwon JS, Levine DA, Shih IeM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian LM.

Cancer Prev Res (Phila). 2016 Sep;9(9):713-20. doi: 10.1158/1940-6207.CAPR-15-0384. Epub 2016 May 24. Review.

50.

Lifetime occupational and leisure time physical activity and risk of Parkinson's disease.

Shih IF, Liew Z, Krause N, Ritz B.

Parkinsonism Relat Disord. 2016 Jul;28:112-7. doi: 10.1016/j.parkreldis.2016.05.007. Epub 2016 May 3.

Supplemental Content

Support Center